ISPE Announces Two Senior Executives and Patient as Keynote Presenters for 2019 ISPE Annual Meeting & Expo

Thursday, October 3, 2019 Press Release
Email Print This Page Comment bookmark
Font : A-A+

The 2019 ISPE Annual Meeting & Expo features a dynamic line-up of thought-provoking keynote presentations led by some of the most prominent names in the pharmaceutical industry. These senior-level presentations are rounded out by a compelling patient keynote speaker.

NORTH BETHESDA, Md., Oct. 3, 2019 /PRNewswire-PRWeb/ -- The International Society for Pharmaceutical Engineering (ISPE)

announced the addition of three new keynote presenters for the 2019 ISPE Annual Meeting & Expo. Taking place 27–30 October 2019 in Las Vegas, Nevada, this signature event brings together top pharmaceutical industry and regulatory leaders offering compelling and enlightening presentations and interactive discussions on industry-critical technical developments.

The 2019 ISPE Annual Meeting & Expo features a dynamic line-up of thought-provoking keynote presentations led by some of the most prominent names in the pharmaceutical industry. These senior-level presentations are rounded out by a compelling patient keynote speaker.

Newly Confirmed Keynote Presenters:

Lou Kennedy, CEO and Owner, Nephron Pharmaceuticals Training Tomorrow's Workforce

Lou Kennedy joined Nephron Pharmaceuticals in 2001 and accepted the position of President and Chief Executive Officer in September 2007. Along with her husband Bill, Kennedy helped establish the Kennedy Pharmacy Innovation Center in conjunction with the USC School of Pharmacy. As CEO of a woman-owned business, Kennedy values female leadership in the workforce.

Alberto Santagostino, Senior Vice President, Head of Cell & Gene Technologies, Lonza AG How to Achieve Industrialization and Bring Curative Therapies to the Masses

Alberto Santagostino has a deep knowledge of the manufacturing challenges faced by companies in the biopharma space. Together with his team at Lonza Pharma & Biotech, the leading global CDMO with a prominent presence in new modalities, Alberto's objective is to serve customers by taking their products through the technical CMC journey to commercialization and industrial scale manufacturing.

Jessica H., Patient Presenter Thriving in My New Normal

Jessica was diagnosed with relapsing MS and after multiple doctors and tests, she discovered ocrelizumab which changed her life by allowing her to treat her body and adjust to her new lifestyle. She has a positive attitude and through sharing of her story encourages others to be their own advocates.

Additional Keynote Presenters Include:

John Crowley, Chairman, Chief Executive Officer, and Co-Founder Amicus Therapeutics When Drug Research is Personal: A Lifetime Journey to Discover, Create and Manufacture Medicines for Rare Diseases

William Anderson, Chief Executive Officer, Roche Pharmaceuticals Every Patient Matters — Transforming to Deliver Breakthroughs Faster

Pierre-Alain Ruffieux, PhD, Head of Global Pharma Technical Operations, Roche Pharmaceuticals Transforming Big Pharma Manufacturing: Dream or Reality?

To learn more about this event and to register, visit http://www.ISPE.org/AM19.

About ISPE The International Society for Pharmaceutical Engineering (ISPE) is the world's largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit http://www.ISPE.org for more information.

For more information, contact: Amy Henry International Society for Pharmaceutical Engineering (ISPE) Tel: +1- 813-960-2105 Email: ask@ispe.org http://www.ISPE.org

 

SOURCE ISPE



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store